These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8220166)

  • 21. Two tyrosine residues in the first transmembrane helix of the human vasoactive intestinal peptide receptors play a role in supporting the active conformation.
    Perret J; Vertongen P; Solano RM; Langer I; Cnudde J; Robberecht P; Waelbroeck M
    Br J Pharmacol; 2002 Aug; 136(7):1042-8. PubMed ID: 12145104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assay of radiolabeled VIP binding and hydrolysis by antibodies.
    Huang H; Paul S
    Methods Mol Biol; 1995; 51():409-15. PubMed ID: 7581713
    [No Abstract]   [Full Text] [Related]  

  • 23. A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes.
    Tsutsumi M; Claus TH; Liang Y; Li Y; Yang L; Zhu J; Dela Cruz F; Peng X; Chen H; Yung SL; Hamren S; Livingston JN; Pan CQ
    Diabetes; 2002 May; 51(5):1453-60. PubMed ID: 11978642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production.
    Du K; Nicole P; Couvineau A; Laburthe M
    Biochem Biophys Res Commun; 1997 Jan; 230(2):289-92. PubMed ID: 9016768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localisation of VIP-binding sites exhibiting properties of VPAC receptors in chromaffin cells of rainbow trout (Oncorhynchus mykiss).
    Montpetit CJ; Shahsavarani A; Perry SF
    J Exp Biol; 2003 Jun; 206(Pt 11):1917-27. PubMed ID: 12728013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of second extracellular loop in the function of human vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide receptor 1 (hVPAC1R).
    Knudsen SM; Tams JW; Fahrenkrug J
    J Mol Neurosci; 2000 Jun; 14(3):137-46. PubMed ID: 10984189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a VIP-specific receptor in guinea pig tenia coli.
    Teng BQ; Grider JR; Murthy KS
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G718-25. PubMed ID: 11518684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A complete substitutional analysis of VIP for better tumor imaging properties.
    Bhargava S; Licha K; Knaute T; Ebert B; Becker A; Grötzinger C; Hessenius C; Wiedenmann B; Schneider-Mergener J; Volkmer-Engert R
    J Mol Recognit; 2002; 15(3):145-53. PubMed ID: 12203840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PACAP, VIP and their receptors in the metazoa: insights about the origin and evolution of the ligand-receptor pair.
    Cardoso JC; Vieira FA; Gomes AS; Power DM
    Peptides; 2007 Sep; 28(9):1902-19. PubMed ID: 17826180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
    J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIP.
    Couvineau A; Gaudin P; Maoret JJ; Rouyer-Fessard C; Nicole P; Laburthe M
    Biochem Biophys Res Commun; 1995 Jan; 206(1):246-52. PubMed ID: 7818527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of vasoactive intestinal peptide receptor (VPAC) signaling in Undifferentiated hen granulosa cells.
    Kim D; Johnson AL
    Mol Reprod Dev; 2018 Dec; 85(12):890-892. PubMed ID: 30114325
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC(2) receptor.
    Moreno D; Gourlet P; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
    Peptides; 2000 Oct; 21(10):1543-9. PubMed ID: 11068102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural difference of vasoactive intestinal peptide in two distinct membrane-mimicking environments.
    Umetsu Y; Tenno T; Goda N; Shirakawa M; Ikegami T; Hiroaki H
    Biochim Biophys Acta; 2011 May; 1814(5):724-30. PubMed ID: 21439408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide 1 receptor. Evidence that asparagine 58 or 69 is crucial for correct delivery of the receptor to plasma membrane.
    Couvineau A; Fabre C; Gaudin P; Maoret JJ; Laburthe M
    Biochemistry; 1996 Feb; 35(6):1745-52. PubMed ID: 8639654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequence of a cDNA encoding chicken vasoactive intestinal peptide (VIP).
    McFarlin DR; Lehn DA; Moran SM; MacDonald MJ; Epstein ML
    Gene; 1995 Mar; 154(2):211-3. PubMed ID: 7890166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autocrine regulation of neuroblastoma cell growth and differentiation by vasoactive intestinal peptide.
    Pence JC; Kerns BJ; Shorter NA
    Prog Clin Biol Res; 1994; 385():269-74. PubMed ID: 7972219
    [No Abstract]   [Full Text] [Related]  

  • 39. Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor.
    Sreedharan SP; Patel DR; Huang JX; Goetzl EJ
    Biochem Biophys Res Commun; 1993 Jun; 193(2):546-53. PubMed ID: 8390245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning and expression of the human vasoactive intestinal peptide receptor.
    Sreedharan SP; Robichon A; Peterson KE; Goetzl EJ
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4986-90. PubMed ID: 1675791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.